TP53 and neoplasm: Kaplan–Meier analysis of the tumor growth delay data, and comparison of the niclosamide-treated and vehicle treated groups in the p53KO tumor cohort using log-rank t-test analysis showed that both curves are statistically significantly different (P < 0.05), in contrast to the p53 wild-type tumor cohort (P > 0.05) (Supplementary Figure 8a, b).